Ignoring SARS-CoV-2 testing performance during COVID-19
- PMID: 36746168
- PMCID: PMC9897733
- DOI: 10.1016/S2666-5247(23)00030-7
Ignoring SARS-CoV-2 testing performance during COVID-19
Conflict of interest statement
HZ is majority owner of Gesellschaft für Biotechnologische Diagnostik; and owner and managing director of Institut für Qualitätssicherung in der Virusdiagnostik. All other authors declare no competing interests.
Comment on
-
The Lancet Commission on lessons for the future from the COVID-19 pandemic.Lancet. 2022 Oct 8;400(10359):1224-1280. doi: 10.1016/S0140-6736(22)01585-9. Epub 2022 Sep 14. Lancet. 2022. PMID: 36115368 Free PMC article. Review. No abstract available.
References
-
- Buchta C, Camp JV, Jovanovic J, et al. Results of a SARS-CoV-2 virus genome detection external quality assessment round focusing on sensitivity of assays and pooling of samples. Clin Chem Lab Med. 2022;60:1308–1312. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
